“…In contrast, in lower risk patients, previous studies have demonstrated a low additional risk of ipsilateral breast recurrence (13,39) and no survival advantage up to 10 years follow up and breast preservation benefits with the omission of radiotherapy in the older age group. (12,40) In the PRIME II study cohort, at 10 years 93.4% of mortality was not due to BC.…”